Nanoparticle player Selecta Biosciences has executed a series of moves today aimed at refocusing its game plan, fueling work on a top program with cash from the NIH and launching a few new initiatives at the busy biotech.

…read more

Source: Selecta ramps up a gout program, gets more cash for vaccine R&D


0 No comments